美托洛尔治疗阵发性室上性心动过速的疗效观察

Efficacy and safety of intravenous metoprolol and verapamil for paroxysmal supraventricular tachycardia

目的观察并比较静脉用美托洛尔与维拉帕米转复阵发性室上性心动过速(PSVT)的有效性及安全性。方法2003年4月至2006年4月入选48例PSVT患者,分为两组,分别静脉用美托洛尔(25例)和维拉帕米(23例),观察转复疗效。结果美托洛尔组及维拉帕米组总有效率分别为80%和86%,差异无显著性意义(P<0.05)。结论美托洛尔和维拉帕米均能有效、安全、快速地终止PSVT。

Objective To evaluate the efficacy of intravenous injection of metoprolol and verapamil for paroxysmal supraventricular tachycardia （ PSVT ）. Methods From April 2003 to April 2006, 48 patients with PSVT were randomized into intravenous injection of metoprolol （ n = 25 ） or verapamil （ n = 23 ） group. Results The effective rate of metoprolol was 80% and verapamil, 86%. Conclusion Both metoprolol and verapamil can effectively, rapidly and safely terminate PSVT.